Lizhi Zhang

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Hum Pathol 42:324-31. 2011
  2. ncbi Autoimmune pancreatitis and IgG4-related systemic diseases
    Lizhi Zhang
    Division of Anatomic Pathology, Mayo Clinic Rochester, Minnesota, USA
    Int J Clin Exp Pathol 3:491-504. 2010
  3. ncbi IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis
    Lizhi Zhang
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 34:88-94. 2010
  4. ncbi Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria
    Lizhi Zhang
    Department of Laboratory and Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Pancreas 40:1172-9. 2011
  5. ncbi KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Am J Surg Pathol 33:1562-9. 2009
  6. ncbi Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
    Amaar Ghazale
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 134:706-15. 2008
  7. ncbi Secondary linitis plastica of the rectum: EUS features and tissue diagnosis (with video)
    Ferga C Gleeson
    Division of Gastroenterology and Hepatology, Department of Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastrointest Endosc 68:591-6. 2008
  8. ncbi Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival
    Javairiah Fatima
    Department of Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arch Surg 145:167-72. 2010
  9. ncbi Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document
    Suresh T Chari
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Pancreatology 10:664-72. 2010
  10. ncbi IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Mod Pathol 20:23-8. 2007

Detail Information

Publications33

  1. ncbi Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Hum Pathol 42:324-31. 2011
    ..By analyzing histopathologic features in KIT/CK19 risk groups, we developed a 3-tiered histopathologic grading system using reproducible parameters (mitoses, tumor necrosis, and infiltrative border) that are easy to apply in practice...
  2. ncbi Autoimmune pancreatitis and IgG4-related systemic diseases
    Lizhi Zhang
    Division of Anatomic Pathology, Mayo Clinic Rochester, Minnesota, USA
    Int J Clin Exp Pathol 3:491-504. 2010
    ..In this article, we review the literature and our own experience to detail the clinicopathologic features of AIP and extrapancreatic lesions in ISD...
  3. ncbi IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis
    Lizhi Zhang
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 34:88-94. 2010
    ..PSC with tissue IgG4 positivity has a more aggressive clinical course manifested by shorter time to transplant and a higher likelihood of recurrence than IgG4 negative PSC...
  4. ncbi Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria
    Lizhi Zhang
    Department of Laboratory and Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Pancreas 40:1172-9. 2011
    ..To develop and validate histologic diagnostic criteria for autoimmune pancreatitis (AIP) and its types...
  5. ncbi KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Am J Surg Pathol 33:1562-9. 2009
    ..These results indicate that KIT is a new and independent prognostic marker for PETs. The classification system derived from KIT and CK19 was able to predict clinical behavior of PET...
  6. ncbi Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
    Amaar Ghazale
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 134:706-15. 2008
    ..We describe clinical features, treatment response, and predictors of relapse in IAC and compare relapse rates in IAC with intrapancreatic vs proximal bile duct strictures...
  7. ncbi Secondary linitis plastica of the rectum: EUS features and tissue diagnosis (with video)
    Ferga C Gleeson
    Division of Gastroenterology and Hepatology, Department of Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastrointest Endosc 68:591-6. 2008
    ..Luminal metastases to the GI tract may be seen at the time of the primary diagnosis or may represent evidence of a distant recurrence...
  8. ncbi Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival
    Javairiah Fatima
    Department of Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arch Surg 145:167-72. 2010
    ..To assess the effect of R0 resection margin status and R0 en bloc resection in pancreatoduodenectomy outcomes...
  9. ncbi Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document
    Suresh T Chari
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Pancreatology 10:664-72. 2010
    ..While most experts agreed that the entities should be referred to as type 1 and type 2 AIP, respectively, others had concerns regarding use of the term 'autoimmune' to describe IDCP. and IAP...
  10. ncbi IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Mod Pathol 20:23-8. 2007
    ..We rarely see IgG4 staining in patients with chronic alcoholic pancreatitis and pancreatic ductal adenocarcinoma. IgG4-positive plasma cells are a useful marker for the tissue diagnosis of autoimmune pancreatitis...
  11. ncbi Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas
    Thomas Schnelldorfer
    Division of Gastroenterologic and General Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Arch Surg 143:639-46; discussion 646. 2008
    ..Intraductal papillary mucinous neoplasm (IPMN) is an increasingly recognized disease of the pancreas. We report our experience with pancreatic resection for IPMN...
  12. ncbi Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document
    Suresh T Chari
    Mayo Clinic, Rochester, MN, USA
    Pancreas 39:549-54. 2010
    ..Whereas most experts agreed that the entities should be referred to as type 1 and type 2 AIP, respectively, others had concerns regarding use of the term "autoimmune" to describe IDCP...
  13. ncbi Idiopathic duct-centric pancreatitis: disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Pancreatology 11:76-80. 2011
    ..The TCB histology was definitive (n = 4) or suggestive (n = 1) for type 2 AIP. No complications developed. Conclusions: EUS-TCB may be safe and may provide sufficient material to definitively diagnose type 2 AIP. and IAP...
  14. ncbi Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: surgical treatment and outcomes
    Daniel Cusati
    Department of Surgery, Mayo Clinic Rochester, Rochester, MN 55905, USA
    J Am Coll Surg 215:117-24; discussion 124-5. 2012
    ..Our hypothesis was that the surgical treatment of metastatic nPNEC provides favorable perioperative and oncologic outcomes...
  15. ncbi Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma
    Lizhi Zhang
    Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 31:1191-5. 2007
    ..The presence of PanIN in heterotopic pancreas from patients with ductal adenocarcinoma supports the progression model...
  16. ncbi Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 4:1010-6; quiz 934. 2006
    ..AIP has unique histologic features associated with infiltration of tissues of affected organs with abundant IgG4-positive cells. We propose expanded diagnostic criteria for AIP with a cohort of histologically confirmed AIP...
  17. ncbi Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care
    Rory L Smoot
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Am Coll Surg 207:368-70. 2008
    ..Previous literature has reported dismal survival for these patients. We examined our single-institution experience with this tumor to compare survival for sugical resection and palliative therapy...
  18. ncbi Diagnosis of IgG4-related tubulointerstitial nephritis
    Yassaman Raissian
    Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1 Street SW, Rochester, MN 55905, USA
    J Am Soc Nephrol 22:1343-52. 2011
    ..When the disease manifests in the kidney, our data support diagnostic criteria that can distinguish IgG4-TIN from other types of TIN...
  19. ncbi Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms
    Taofic Mounajjed
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Hum Pathol 44:542-50. 2013
    ..As these tumors commonly metastasize to the liver, this offers a potential pitfall in differentiating between HCC and metastatic carcinoma when evaluating tumors involving the liver...
  20. ncbi Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases
    Rondell P Graham
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 37:399-405. 2013
    ..Our findings confirm that Isl1 is a sensitive marker of pancreatic origin in cases of metastatic NEN. However, Isl1 does not distinguish pancreatic NEN from duodenal and colorectal NEN, even when used in association with CDX2...
  21. ncbi Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection
    Timucin Taner
    Departments of Surgery Radiology Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
    HPB (Oxford) 15:190-5. 2013
    ..Ablation performed intra-operatively and repeated post-operatively as needed provides significant symptom control regardless of the tumour grade...
  22. ncbi Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
    Benjamin R Kipp
    Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hum Pathol 43:1552-8. 2012
    ..The results of this study are encouraging because it identifies a new potential target for genotype-directed therapeutic trials and may represent a potential biomarker for earlier detection of cholangiocarcinoma in a subset of cases...
  23. ncbi Histologic and imaging features of mural nodules in mucinous pancreatic cysts
    Ning Zhong
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 10:192-8, 198.e1-2. 2012
    ..We assessed images and the histology of mural nodules in branch duct intraductal papillary mucinous neoplasms (BD-IPMNs) and mucinous cystic neoplasms (MCNs) and identified criteria to distinguish mural nodules from mucus...
  24. ncbi Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Thomas Schnelldorfer
    Division of Gastroenterologic and General Surgery Mayo Clinic, Rochester, MN 55905, USA
    Ann Surg 247:456-62. 2008
    ..To determine long-term survival after pancreatoduodenectomy for pancreatic ductal adenocarcinoma and to identify clinical factors associated with long-term survival...
  25. ncbi Adequacy of endoscopic ultrasound core needle biopsy specimen of nonmalignant hepatic parenchymal disease
    Ferga C Gleeson
    Fiterman Centre for Digestive Disease, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 6:1437-40. 2008
    ..Therefore, our aim was to determine the adequacy of endoscopic ultrasound (EUS)-guided Trucut liver biopsy for histopathologic evaluation to include the number of complete portal tracts contained per millimeter of acquired tissue...
  26. ncbi Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice
    Zheng Fu
    Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    J Clin Invest 119:2714-24. 2009
    ..These results suggest that defects in both Chfr and Mlh1 synergistically increase predisposition to tumorigenesis...
  27. ncbi Endoscopic ultrasound fine-needle aspiration detection of extravascular migratory metastasis from a remotely located pancreatic cancer
    Michael J Levy
    Fiterman Centre for Digestive Disease, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 7:246-8. 2009
    ..Our objective was to report the presence of malignant perivascular cuffing of the celiac axis in a patient with an apparently early T stage and resectable pancreatic cancer...
  28. ncbi Eosinophilia and allergic disorders in autoimmune pancreatitis
    Raghuwansh P Sah
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 105:2485-91. 2010
    ..In autoimmune pancreatitis (AIP), the prevalence, interrelationships, and significance of peripheral eosinophilia, allergic disorders, and eosinophil infiltration in the pancreas remain unclear...
  29. ncbi Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis
    Rondell P D Graham
    Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 36:732-6. 2012
    ..In conclusion, the detection of a Langerhans cell infiltrate of ≥2 cells by CD1a in a given bile duct on needle biopsy may be a valuable tool in the diagnosis of PBC...
  30. ncbi Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma
    Abdul M Oseini
    Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Hepatology 54:940-8. 2011
    ..Depending on the prevalence of the two diagnoses, the use of a 2-fold cutoff for sIgG4 may not reliably distinguish IAC from CCA. At a cutoff of 4 times the upper limit of normal, sIgG4 is 100% specific for IAC...
  31. ncbi Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice
    Matthew Rowley
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
    Gastroenterology 140:1303-1313.e1-3. 2011
    ....
  32. ncbi Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases
    Lizhi Zhang
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 34:53-64. 2010
    ..Thus, the Carney triad gastric stromal tumor is different clinically, pathologically, and behaviorally from sporadic gastric GIST...
  33. ncbi USP10 regulates p53 localization and stability by deubiquitinating p53
    Jian Yuan
    Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Cell 140:384-96. 2010
    ..These findings reveal USP10 to be a novel regulator of p53, providing an alternative mechanism of p53 inhibition in cancers with wild-type p53...